News

BioLife Solutions has entered into a license and custom cGMP manufacturing agreement with Centocor Research & Development. The agreement includes the production of a custom variant of BioLife’s

Novo Nordisk has initiated its first Phase 1 clinical trial with an oral insulin analogue (NN1952). This milestone releases a $2m payment to Merrion whose Gipet technology is

Alethia Biotherapeutics (Alethia) has obtained the exclusive worldwide diagnostic rights to a peptide that specifically binds to tumor-associated clusterin from the National Research Council Biotechnology Research Institute (NRC-BRI)

Medco Health Solutions (Medco) has reported that its majority-owned subsidiary, Europa Apotheek Venlo, has acquired shop-apotheke.com, an online OTC and healthcare products site. The combined businesses intend to

Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus’ Dedicated Research Centres to

Cyntellect has entered into a research collaboration agreement with the Boston University School of Medicine. The agreement focuses on advancing research in the roles of mitochondrial oxidative damage

MicroPhage has obtained CE Mark to market in Europe the first of its instrument-free, rapid tests based on its patented Bacteriophage amplification technology. The company’s initial commercial product

Bayer Schering Pharma (Bayer Schering) has completed the decentralised part of drug approval procedure in Europe for a new treatment of endometriosis called Visanne. Visanne is a once-daily

NutraRx has entered into a distributor partnership with Emerson Ecologics. Emerson Ecologics will now be carrying the entire NutraRx line, enabling practitioners to save valuable time and money